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Just two Sides of the Same Coin? Ethical Issues  
and Discourses on COVID-19 and Ebola.  
A Comparative Literature Analysis 
Saskia Wilhelmy, Rebecca Ulrich & Dominik Groß 
Abstract: »Nur zwei Seiten derselben Medaille? Ethische Fragen und Diskurse 
über COVID-19 und Ebola. Eine vergleichende Literaturanalyse«. Infectious dis-
eases pose a continuing threat to human life. In the case of pandemics, they 
can also grow into massive challenges for society as a whole – not only from 
a medical but also from an ethical perspective. This article takes the current 
COVID-19 pandemic as the occasion for an empirical medico-ethical analysis. 
It explores the ethical dimensions and discourses on COVID-19 and the Ebola 
epidemics (West Africa, Democratic Republic of Congo). Additional attention 
is paid to the question whether and to what extent the ethical issues raised 
differ and how the possible disparities can be explained. Using a methodo-
logical two-step approach (systematic literature review; qualitative content 
analysis), we were able to identify nine categories that map the ethical di-
mensions of recent outbreaks of these two diseases: (1) Prioritization of 
health, (2) Equitable access to resources, (3) Adequate information, (4) Health 
worker vulnerability, (5) Stigma and discrimination, (6) Research ethics, (7) 
Measures restricting freedom, (8) Global health justice, (9) Environmental 
ethics.  
Keywords: Medical ethics, moral values, disease outbreak, pandemic, infec-
tious disease, lessons learned, qualitative research, categorization. 
1. Introduction 
After the World Health Organization (WHO) first declared a Public Health 
Emergency of International Concern (PHEIC) for pandemic H1N1 influenza 
in 2009, four other infectious diseases with this status have followed to date, 
including two Ebola epidemics in West Africa (2013–2015) and the 
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Democratic Republic of Congo (DRC, 2018–2020) and the recent COVID-19 
pandemic (Wilder-Smith and Osman 2020), which is still virulent. 
Outbreaks of this magnitude pose not only medical and public health chal-
lenges, but also ethical ones. This is already evident in the WHO’s response 
in 2015 with a training manual, “Ethics in Epidemics, Emergencies, and Dis-
asters,” for research and patient care (WHO 2015). But are the ethical chal-
lenges of Ebola and COVID-19 even comparable? And most importantly, are 
they perceived similarly and discussed analogously, or do the differences pre-
dominate? 
These are precisely the questions that form the starting point of our analy-
sis. The aim of this paper is to trace the ethical discourses on the COVID-19 
pandemic and the recent Ebola epidemics on the basis of a broad literature 
review and to identify thematic foci. Beyond the actual comparison, we are 
interested in how any differences can be explained and interpreted. 
2. Methodology 
The comparative analysis of the ethical discourses on the Ebola and COVID-
19 outbreaks presented here was based on a two-stage procedure: First, a sys-
tematic literature review was conducted; this was followed by a qualitative 
content analysis according to Mayring (2014). The review covers the period 
from the start of the COVID-19 outbreak in late 2019 to May 2021 (the first 
articles on COVID-19 related to Ebola were published in January 2020); con-
tent included both the 2013–2016 Ebola epidemic in West Africa and all sub-
sequent outbreaks in the Democratic Republic of Congo (DRC; 2018–2020), 
i.e., Ebola outbreaks before and during the COVID-19 pandemic published dur-
ing the study period (2020–2021) were included. 
2.1 Search Strategy 
To find relevant articles on the topic, the online research platform “Web of 
Science”1 was used, which provides access to scientific citation and literature 
databases. The platform enables an interdisciplinary search for articles from 
the academic disciplines of medicine, natural sciences, humanities, social 
sciences, and economics. This interdisciplinarity was critical to the article 
search because disease outbreaks are events that affect society as a whole 
and, accordingly, are reflected in many scientific disciplines. Furthermore, 
the discussion of ethical issues of this magnitude was not limited to any spe-
cific discipline. On the contrary, such ethical implications are considered to 
have a societal significance that transcends disciplinary boundaries. 
 
1  Web of Science: https://www.webofscience.com. 
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Accordingly, to ensure a comprehensive view of the ethical dimension of re-
cent outbreaks of the two diseases, an examination of articles from different 
disciplines was essential. 
The search strategy included a combination of keywords related to the two 
terms “Ebola” and “COVID” (search query: [ALL=((ebola OR EVD) AND (covid 
OR corona OR sars))]. Additionally, we filtered for language (English only), 
publication date (timespan 2020–2021), and document type (articles). A com-
bined search with the term complex on “ethics” (e.g., morale, value) was 
avoided in this search step: first, to obtain a broader search result and, sec-
ond, due to the assumption (later confirmed) that ethical topics are also in-
cluded in articles that do not use the term complex “ethics” but address ethi-
cal topic spectrums with terms such as justice, solidarity, or responsibility. 
The researched articles were then examined according to predetermined 
criteria. Exclusion conditions were also established: articles that were not 
available online as full text (approximately 5% of articles), in which neither 
Ebola nor COVID was a topic (approximately 10%; e.g., listed only in key-
words), in which only one of the two infectious diseases was addressed with-
out reference to the other (articles only on Ebola: approximately 5%; and only 
on COVID: approximately 60%), or articles in which SARS-CoV-1 was ad-
dressed rather than SARS-CoV-2 or COVID-19 were not considered. 
2.2 Categories Extraction 
To extract the discussed ethical issues of the Ebola and COVID-19 outbreaks 
from the articles, a qualitative content analysis according to Mayring (2014) 
was performed using deductive category assignment. To do so, we derived 
corresponding categories from 11 normative challenges to COVID-19 that 
were addressed in Groß (2020).2 The articles we researched were filtered to 
determine whether such themes were reflected in their content and then sub-
sumed under the categories accordingly (deductive category assignment). 
Content from articles in which ethical issues are discussed as well as those in 
which they are merely mentioned were considered. The categories of Groß 
(2020) served as a dynamic and thus changeable starting point and were 
adapted or extended depending on the content of the articles (inductive cate-
gory assignment). The review and evaluation of all articles was performed in 





2  The categories are: 1) adequate information, 2) measures restricting freedom, 3) individual sol-
idarity obligations, 4) generational solidarity, 5) prioritization of health, 6) triage and prioritiza-
tion criteria, 7) patient autonomy, 8) research ethics, 9) equal access to resources, 10) endan-
gered health care workers, 11) renormalization processes. 
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3. Results 
3.1 Quantitative Results and Bibliometric Characteristics 
The systematic literature search yielded a total of 444 professional articles 
based on the defined keyword combination of “Ebola” and “COVID.” After re-
viewing the articles using predefined criteria, the number of articles was re-
duced to 58. Qualitative content analysis then led to the exclusion of a further 
19 articles, resulting in a total sample, and thus database, of 39 articles (see 
appendix). 
A search combination using the term “ethics” and its derivatives was not 
performed for the aforementioned reasons, but these terms were neverthe-
less cross-checked in the articles of the database. Here it was found that “eth-
ical” terms (such as ethics or morale) were used in 24 of the 39 articles – alt-
hough in four articles these referred only to formal aspects, e.g., reference to 
the submission of an ethics statement, compliance with ethical standards, or 
vote of an ethics committee. Nevertheless, these four articles and another 11 
articles in the database had “ethical” content related to Ebola and COVID 
without explicitly using these terms in the text. The total of 39 professional 
articles came from 30 different journals with different scientific focuses (cf. 
table 1), in which 25 articles were published in 2020 and 14 articles in 2021. 
Regarding the affiliations of the authors in the articles, it can be noted that 
they are located in 14 low-income countries (LIC; Sub-Saharan Africa [DRC, 
Mali, Sierra Leone, Uganda], South Asia [Afghanistan]) and lower-middle in-
come countries (LMC; Sub-Saharan Africa [South Africa, Kenya, Nigeria, 
Zambia, Zimbabwe], Middle East & North Africa [Egypt, Iran], South Asia [In-
dia], East Asia & Pacific [Philippines]). Additionally, authors were affiliated in 
17 upper-middle income countries (UMC; East Asia & Pacific [China], Middle 
East & North Africa [Lebanon], Latin America & Caribbean [Peru]) and high-
income countries (HIC; East Asia & Pacific [Australia, Hong Kong, Singa-
pore], Europe & Central Asia [Austria, Belgium, Germany, Netherlands, Nor-
way, United Kingdom (UK), Sweden, Switzerland], Middle East & North Africa 
[Saudi Arabia], North America [Canada, United States (US)]). 
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Table 1 Bibliometric Characteristics of the Journals in our Database (n = 30 
journals, n = 39 articles) 
Journal Journal contrib. by 
country/region 
(rank 1/rank 2)* 
Journal rubric** Freq. of  
articles (n) 
1. African Journal of  




Primary health care  1 
2. AIMS Public Health USA/Iran Health care sciences and services 1 
3. American Journal of 
Tropical Medicine and 
Hygiene 
USA/UK Public, environmental, and  
occupational health; Tropical  
medicine 
2 
4. BMC Public Health USA/UK Public, environmental, and  
occupational health 
2 
5. Critical Public Health UK/USA Public, environmental, and  
occupational health; Social  
sciences, biomedical 
1 
6. Developing World  
Bioethics 
 Ethics; Medical ethics 2 
7. Environment  Environmental sciences;  
Environmental studies 
1 
8. Epidemiologia &  
Prevenzione 
Italy/UK Public, environmental, and  
occupational health 
1 
9. Frontiers in Psychology USA/China Psychology, multidisciplinary 2 
10. Healthcare 
 
USA/South Korea Health care sciences and services 1 
Health policy and services 
11. Health Security USA/UK Public, environmental, and  
occupational health 
1 
12. International Journal of 
Infectious Diseases 
USA/China Infectious Diseases 1 
13. International  
Organization 
USA/UK Political science 1 
International relations 
14. Journal of Bioethical  
Inquiry 
Australia/USA Ethics 3 
Medical ethics 
Social issues 
Social sciences, biomedical 
15. Journal of Black  
Studies 
USA/South Africa Ethnic studies 1 
Social sciences, interdisciplinary 
16. Journal of Global  
History 
USA/UK History 1 
17. Journal of Health  
Communication 
USA/Singapore Communication; Information  
science and library science 
1 
18. Journal of Human  
Behavior in the Social 
Environment 
USA/South Africa Social work 1 
19. Journal of Medical  
Ethics 
UK/USA Ethics; Medical ethics; Social issues; 
Social sciences, biomedical 
2 
20. Journal of Psychiatric 
Research 
USA/China Psychiatry 1 
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21. Journal of the Royal  
Anthropological  
Institute 
USA/UK Anthropology 1 
22. npj Vaccines USA/UK Immunology; Medicine, research, 
and experimental 
1 
23. Pan African Medical 
Journal 
Morocco/Nigeria Public, environmental, and  
occupational health 
1 
24. Public Health Reports USA/Canada Public, environmental, and  
occupational health 
1 
25. Social Studies of  
Science 
USA/UK History and philosophy of science 1 
26. Tropical Medicine and 
Infectious Disease 
USA/Australia Infectious diseases; Parasitology; 
Tropical medicine 
1 
27. Vaccines USA/Italy Immunology; Medicine, research, 
and experimental 
1 
28. Wiener Klinische  
Wochenschrift 
Austria/Germany Medicine, general, and internal 1 
29. World Development USA/UK Development studies; Economics 3 
30. Yale Journal of Biology 
and Medicine 
USA/Australia Biology 1 
* Countries/Regions that have contributed the most papers to the journal in the most recent three-
year period, indexed by Journal Citation Reports (JCR; Clarivate, https://jcr.clarivate.com/ 
jcr/home (Accessed August 10, 2021); **Journal rubrics in which the Journals were categorized by 
JCR. 
3.2 Qualitative Results of the Content Analysis and Extracted 
Categories 
The results of the qualitative content analysis provide insights into the range 
of ethical challenges addressed in the articles comparing the Ebola and 
COVID-19 disease outbreaks. Based on the 11 categories of Groß (2020) that 
served as the starting point for deductive analysis of the articles, the content 
of the articles in our database could ultimately be subsumed into six of these 
categories. Accordingly, five categories were not picked up in the articles, 
namely (3) individual solidarity obligations, (4) generational solidarity, (6) tri-
age and prioritization criteria, (7) patient autonomy, and (11) renormalization 
processes. Newly added, i.e., inductively generated from the article contents, 
were three categories: stigma and discrimination, global health justice, and 
environmental ethics. 
The qualitative content analysis thus yielded a total of nine (deductively and 
inductively obtained) categories from our article database (cf. table 2). Within 
an article, several different categories could be represented, and some cate-
gories had subcategories. In the following, the categories are presented, or-
dered by the frequency of their occurrence in the articles. 
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Table 2 Generated Ethics Categories on Ebola and COVID-19 
Categories Freq. of articles with 
these categories (n) 
Type of category 
assignment 
Assignment of ethical 
principles* 
1. Prioritization of health  15 deductive beneficence,  
non-maleficence,  
autonomy 
2. Equal access to  
resources  
12 deductive justice, solidarity 
3. Adequate information  12 deductive beneficence,  
non-maleficence 
4. Endangered health 
care workers 
6 deductive beneficence,  
non-maleficence, 
justice, solidarity 
5. Stigma and  
discrimination  
6 inductive beneficence,  
non-maleficence,  
justice, solidarity 
6. Research ethics 5 deductive beneficence,  
non-maleficence 
7. Measures restricting 
freedom 
4 deductive autonomy,  
beneficence,  
non-maleficence 
8. Global health justice 4 inductive justice, solidarity 
9. Environmental ethics 2 inductive beneficence,  
non-maleficence,  
justice, solidarity 
* Referring to the “Principles of Biomedical Ethics” (Beauchamp and Childress 2009) regarding dis-
ease outbreaks according to Druml (2020). 
 
Category 1: Prioritization of health  
The category that appeared most frequently in the articles was that of “prior-
itizing health.” This refers to the view of health as an absolute good, accom-
panied by the demand to do everything possible to keep people healthy or 
protect them from death. This view is especially valid for major disease out-
breaks that affect public health, such as Ebola or COVID-19. The opposite po-
sition is to regard health not as an absolute good, but as an equal good along-
side other goods. Accordingly, it would be just as legitimate not to invest all 
available resources in the protection and promotion of health during a dis-
ease outbreak, and thus to accept the death of people, in order to also grant 
other aspects of (public) life, since they also have an influence on the life ex-
pectancy, quality, and opportunities (education, infrastructure, crime con-
trol, civil liberties, etc.). The articles examined address these weighting is-
sues, noting in particular that other aspects of (public) life are eclipsed or 
neglected by disease outbreak control. 
Four different subcategories could be identified. (a) Socioeconomic impact: 
Due to the priority given to disease outbreak control, there are adverse side 
effects such as loss of income, difficulty in meeting food needs, and increased 
crime. (b) Impact on other diseases: By prioritizing protective measures for 
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disease outbreaks, prevention of other diseases in the population is neglected 
or discontinued, making them an increased (latent) health threat to people. 
(c) Impact on vulnerable groups: Disease outbreak control measures displace 
the needs and protection of vulnerable populations (e.g., gender-based vio-
lence against women). (d) Impact on cultural practices: Disease outbreak 
control measures partially compromise or destroy previous cultural or tradi-
tional practices (e.g., funeral rituals, which impedes grief recovery). 
 
Category 2: Equal access to resources  
A total of 12 articles had content that fell under the category of “equal access 
to resources.” This included equitable access to health-sustaining, life-saving, 
or medical resources and ultimately preventive measures during outbreaks 
of Ebola and COVID-19. By not providing equal access to certain resources, 
people can be disadvantaged or harmed. Three specific access issues are to 
be grouped under this category, each affecting different resources. (a) Access 
to protective materials: insufficient access to resources to contain a disease 
outbreak (testing, protective equipment, health workers, hygiene items, san-
itation, etc.) leads to further spread of a disease and endangerment of people. 
(b) Access to research: access to research and corresponding research results 
is not equally guaranteed, so that derived information for combating a dis-
ease outbreak is not equally available to all. (c) Access to technology: use of 
unadapted technology in regions where digital divide exists is not effectively 
applicable. 
 
Category 3: Adequate information 
The category “adequate information” was present just as frequently as the 
category “equal access to resources” (n = 12 articles). It describes the adequate 
information and education of the public regarding available medical 
knowledge and appropriate measures in the event of disease outbreaks by 
medical experts, health politicians, government representatives, scientists, 
or media representatives. They have a special responsibility to the public to 
provide appropriate information and knowledge, i.e., the current state of 
available scientific information, or to meet the requirement of care, for ex-
ample, to counteract panic, fears, or false actions. A special role is played in 
this context by so-called fake news, especially during the COVID-19 outbreak. 
Fake news can achieve a high reach and lead to risky actions or negligent be-
havior; moreover, such fake news counteracts the requirement of truthful-
ness (veracity). 
 
Category 4: Endangered health care workers 
Articles that specifically addressed the hardships faced by health care work-
ers as a result of their work during disease outbreaks such as Ebola and 
COVID-19 were subsumed under the category of “endangered health care 
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workers” (n = 6 articles). Health care workers involved in the medical care of 
infected Ebola or COVID-19 patients faced particular hardships. This con-
cerns, on the one hand, the increased stressful working conditions due to pro-
tective measures and, on the other hand, the increased risk of infection – both 
of which pose a health threat and both of which have an ethical dimension at 
the same time. The content of the articles assigned to this category shows, on 
the one hand, the health and psychological effects caused by health workers 
in crisis situations (e.g., fear of infecting family members). On the other 
hand, it discusses what it means to be part of the safety-sensitive persons and 
whether it is ethically justifiable for health care personnel to refuse to care 
for infected patients for their own safety or what special duties they have in 
society. 
 
Category 5: Stigma and discrimination 
This inductively obtained category concerns the stigma and also various 
forms of discrimination faced by individuals as a result of disease outbreaks 
such as Ebola and COVID-19 (n = 6 articles). Severe or uncontrollable disease 
outbreaks are often accompanied by anxiety, feelings of powerlessness, or 
even anger, which can take the form of increased stigma toward individuals 
or even discriminatory actions. Among these, different views can be found in 
the articles, which consider both existing and increased negative attitudes to-
wards marginalized groups during disease outbreaks as well as the resulting 
health consequences, such as an increased mortality rate. 
 
Category 6: Research ethics 
The category “research ethics” comprises different contents of articles (n = 5 
articles), which are related to ethical aspects of clinical research on humans 
concerning outbreaks of diseases like Ebola and COVID-19. These include 
considerations of vaccine development (e.g., pressure to act vs. safe research, 
ethical defensibility of vaccine research, or consideration of placebo in study 
design), mistrust of developed vaccines due to past poor research (esp. vac-
cine hesitancy), or use of vaccines that have not yet been sufficiently tested 
(esp. compassionate use). 
 
Category 7: Measures restricting freedom 
A measure used in disease outbreaks to contain the spread between people is 
quarantine or isolation – this containment measure played a role in both the 
Ebola and COVID-19 outbreaks. The category “measures restricting freedom” 
summarized content from articles (n = 4 articles) that encompass ethical chal-
lenges related to this form of prevention, which are caught between the need 
for solidarity (to protect all) and negative consequences of isolation (individ-
uals); including the effects of isolation on patients, their relatives, and on 
health care workers, the renegotiation of closeness and distance in the social 
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context, the influence on privacy through control measures (case tracking), 
and the general consideration of the restriction of freedom as a violation of 
fundamental rights. 
 
Category 8: Global health justice 
Another inductively derived category, titled “global health justice,” includes 
content from three articles that address social justice in terms of fair distri-
bution of resource, rights, and opportunities at the global level in relation to 
disease outbreaks such as Ebola and COVID-19. The category includes con-
tent that addresses the demand for a solidarity-based “whole-of-world” ap-
proach and criticizes the failure of previous solidarity-based approaches and 
the withdrawal from international solidarity during disease outbreaks. 
 
Category 9: Environmental ethics 
The category “environmental ethics” (n = 2 articles), also obtained induc-
tively, includes content that reflects ethically on the interplay between hu-
man health and the environment. This included, first, an article that gener-
ally addresses the lack of ecological perspective on the interaction of humans 
and nature and the resulting steady health impact of disease outbreaks. And 
secondly, an article that discusses the amplification of climate change 
through disease outbreak control and that safety measures (such as disposa-
ble materials) against disease outbreaks pollute the environment (through 
waste, chemical agents). 
4. Discussion 
Our study sought to examine the ethical challenges that come to light in the 
context of disease outbreaks in a comparative analysis between Ebola and 
COVID-19. In particular, the focus of the study was on the ethical discourses 
and possible disparities between these outbreaks – i.e., how are ethical chal-
lenges related to these different disease outbreaks? Does the localization of 
Ebola outbreaks in West and Central Africa and the global spread of the 
COVID-19 pandemic impact (different) ethical challenges? In the following, 
the quantitative and qualitative research results are critically reflected. 
4.1 Lessons Learned 
Qualitative examination of the articles (n = 39 articles) revealed that despite 
the very different viral genera and resulting diseases, the ethical dimensions 
of the Ebola and COVID-19 outbreaks have numerous similarities. “Lessons 
learned” play a special role in this context. This popular term, which has 
found expression in the field of project and knowledge management, plays a 
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particularly important role in the field of emergency and crisis management. 
The term is used to describe experiences from activities or events that should 
be taken into account for future actions – for example, related to the spread 
of infectious diseases, living with, or surviving after an outbreak with high 
infection rates. Numerous studies can be found that look at lessons learned 
from individual disease outbreaks, including for Ebola (Coltart et al. 2017; 
Quaglio et al. 2016) or for COVID-19 (Khanna et al. 2020; Fang et al. 2021). Dis-
tilling lessons learned for future action can also be applied to the ethical di-
mension of a disease outbreak, or the ethical challenges that may arise in the 
context of an outbreak. In our database, we found that a large proportion of 
articles identified specific lessons learned from Ebola outbreaks, which were 
then related to the COVID-19 pandemic with varying summations, such as cit-
ing that there was a reinforcement of ethical challenges in COVID-19 that 
were already identified in Ebola; one article explicitly criticizes the failure to 
draw appropriate (moral) consequences from the available evidence. In total, 
18 articles explicitly use the phrase “lessons learned” with reference to expe-
riences from past outbreaks – 78% of these articles explicitly refer to Ebola 
outbreaks (from recent outbreaks in 2013–2016 and 2018–2020) and 22% make 
general references to previous outbreaks without specifying them in more 
detail. 
4.2 Differentiated Authorships, Differentiated Perspective 
Our methodological approach, i.e., searching and examining articles com-
paring both the Ebola outbreaks and COVID-19 pandemic, allowed us to con-
duct a nuanced analysis of the ethical dimension. COVID-19 is a global chal-
lenge for countries, while the Ebola outbreaks were seen as a primary 
challenge of LICs, specifically West Africa and parts of Central Africa. Link-
ing the outbreaks of these two infectious diseases to each other in our study 
allowed for transnational and national perspectives. On the one hand, a trans-
national view by using comparisons to past Ebola outbreaks in African coun-
tries as a reference point for understanding or reappraising COVID-19 in a 
wide variety of countries worldwide. On the other hand, national perspec-
tives are made possible, starting from countries that have experienced and 
survived Ebola and now have the additional challenges of a COVID-19 pan-
demic. Both perspectives contribute to a more nuanced picture of the ethical 
dimension of outbreaks. 
These perspectives (transnational and national) are also reflected in the 
bibliometric characteristics of the articles from our database, considering au-
thors’ affiliations on the one hand and research collaborations on the other. 
In total, authors from 17 different HICs/UMCs and from a total of 14 
LICs/LMCs are represented in the articles. Out of a total of 39 articles in the 
database, 19 articles are written by authors who reside exclusively in 
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HICs/UMCs and 5 articles indicate authors who reside exclusively in 
LICs/LMCs. This finding is also consistent with the ranking of the contribu-
tions of papers to the journals from our database (cf. table 1); here, too, 
HICs/UMCs are predominantly represented in the first two places of the rank-
ing (in a total of 26 journals) and LICs/LMCs are represented in only 10 jour-
nals. That HICs/UMCs are overrepresented in research is a well-known fact 
(Plancikova, Duric, and O’May 2020) – at the same time it can be noted that 
there is a steady upward trend in terms of research (involvement) in health 
research in LICs/LMCs (Franzen, Chandler, and Lang 2017) or the rise of 
global collaboration over the last decades (Dimitris, Gittings, and King 2021; 
Maher and Van Noorden 2021). These two aspects are also reflected in our 
database, both in the journal characteristics and in those of the articles; for 
example, we note that a total of 12 articles in our database are “research col-
laborations,” meaning that authors affiliated in both LICs/LMCs and 
HICs/UMCs were jointly involved. Collaborations with authors affiliated in 
African countries are particularly frequent (n = 9 articles) – this can be ex-
plained by the fact that the affiliations were equated with the countries in 
West and Central Africa where the Ebola outbreaks occurred. 
4.3 Maintaining Health at any Price? 
“Health is not everything, but without health, everything is nothing” – what 
the medically knowledgeable German philosopher Arthur Schopenhauer 
(1788–1860) once formulated as a wisdom of life encompasses an ethical di-
lemma that was revealed to an increased degree during the COVID-19 pan-
demic. Health is a nonnegotiable good and thus preserving it at all costs sug-
gests a position that is reflected in the public health sector, especially in 
measures of infection protection in the current pandemic fight. Protective 
measures used against coronavirus include, for example, typical infection 
control measures such as the use of protective clothing like gloves, face 
masks, gowns (exposure prevention), the administration of vaccinations (dis-
position prevention), or the use of custodial measures such as mass quaran-
tine.  
There were protests around the world about the proportionality of the 
measures used – on the one hand because of inadequate protection against 
the virus (see the discussion on category 2 “Equal access to resources”), or on 
the other hand because of excessive protection against the virus. The latter is 
reflected as a critique of it in the content of the articles that were subsumed 
under the most comprehensive category “Prioritization of health.” It could be 
identified in different contexts for both the Ebola outbreaks and the COVID-
19 pandemic; the main focus here was the prioritization of health, i.e., the 
increased use of protective measures against the virus and the focus on 
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pandemic control, which ultimately led to the neglect of other areas of life 
and health in African countries (sub-Saharan Africa). 
One of the four impacts of prioritization relates to socioeconomic aspects 
or civil security. Inadequate income security, job loss, or general financial 
problems have been the results of COVID-19 prevention efforts in several sub-
Saharan African countries (Juma et al. 2020; Erlach et al. 2021; Stoop et al. 
2021). 
In African countries (sub-Saharan-Africa), COVID-19 was found to lead to 
stronger protective measures than the more deadly Ebola. This was less due 
to high COVID-19 case numbers, as these were relatively low on the African 
continent at the start of the pandemic (this statement must be qualified, as it 
was retrospectively determined that the number of cases was higher than in-
dicated due to insufficient testing capacities, cf. Mulenga et al. 2021), but ra-
ther to the high risk of infection, compared to the Ebola virus (Stoop et al. 
2021). This was undoubtedly due to the internationally established standards 
of COVID-19 control – while there were no global strategies for the control of 
the Ebola epidemics. Due to the poverty in African countries (sub-Saharan-
Africa), the protective measures implicitly led to further health problems, 
which were directly manifested by (psychological) stress, (existential) fears 
(Erlach et al. 2021), or insufficient food security (Juma et al. 2020; Richards 
2020; Afolabi et al. 2021); shortages in food supply due to sick people in the 
food sector also led to hunger (Smyth 2020). Indirect effects on health were 
non-use of health services due to poverty or travel restrictions (Colombo et 
al. 2020) or use of health services in other regions due to lack of support ser-
vices in one’s own area, which drove spreading of the SARS-CoV-2 virus (Juma 
et al. 2020). The poverty and hunger consequences due to measures that were 
actually intended to protect people led to incomprehensibility and incompli-
ance with the restrictions (Nachega et al. 2020). Thus, of all things, the 
measures taken to protect the population had significant negative ethical con-
sequences – precisely because the framework conditions in African countries 
(sub-Saharan-Africa) were not comparable to those in the industrialized na-
tions. 
All of the aforementioned socioeconomic and normative impacts of protec-
tive measures were already known in Ebola outbreaks, but those measures 
were more restrictive in COVID-19 (e.g., increased travel restrictions, shut-
ting down the economy) and resulted in more severe consequences for af-
fected people. Because of these consequences, restrictions have been relaxed 
in some countries, for example, in Sierra Leone the travel restrictions be-
tween the 14 districts in order to maintain the nutrition of the population 
(Richards 2020); i.e., a trade-off was made here in terms of whether to accept 
“health at any cost” with these consequences ultimately harmful to people’s 
health after all. 
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Explicitly, this reversal of the intended goal of promoting or maintaining 
health through prioritization becomes apparent when considering the impact 
on other diseases. During the COVID-19 pandemic, global attention was fo-
cused on this acute health threat as it emerged as a major public health bur-
den with rising morbidity and mortality in the global community (Gebru et al. 
2021) – pushing other life or health threats into the background. The result:  
An increase in non-COVID related, indirect morbidity and mortality […]. 
Most health resources and efforts shift to the response to the epidemic, at 
the expense of essential health care. Health spending is diverted to the epi-
demic control, at the expense of other health needs. (Colombo et al. 2020, 
417-8) 
Already during the Ebola outbreaks in West Africa and the DRC, it was noted 
that the outbreaks led to setbacks in the treatment and control of other or 
even endemic diseases in the population, or an increased burden on health 
systems – additionally and to an increased extent, this can be seen in the 
COVID-19 pandemic (Alene, Wangdi, and Clements 2020; Sasidharan and 
Dhillon 2021). Specific diseases mentioned in this context are malaria, 
HIV/AIDS, measles, and tuberculosis (Ajayi, Ajumobi, and Falade 2020; 
Alene, Wangdi, and Clements 2020; Sasidharan and Dhillon 2021). It is appar-
ent that by focusing on one (acute) disease phenomenon, other diseases (their 
prevention, control, or treatment) can be sidelined, ultimately resulting in an 
increased disease burden and morbidity in a population – or globally in rela-
tion to COVID-19: “We cannot stop or stall our progress toward the eradica-
tion or suppression of such diseases only to face an even greater disease bur-
den once the pandemic has passed” (Smyth 2020, 35). 
Thus, for people who already suffer from diseases, major disease outbreaks 
such as Ebola or COVID-19 pose an additional risk – they belong to the vul-
nerable group of people who are particularly worthy of protection within a 
community. Vulnerable people include  
the economically disadvantaged, racial and ethnic minorities, the unin-
sured, low-income children, the elderly, the homeless, those with human 
immunodeficiency virus (HIV), and those with other chronic health condi-
tions, including severe mental illness. (The American Journal of Managed 
Care 2016, 348) 
The control of acute disease outbreaks thus also protects vulnerable groups, 
but a strong focus on control can also have negative effects on them. This is 
particularly evident among women and girls in LIC and MIC, who have little 
or no access to education (due to prescribed traditional roles, power dynam-
ics, social inequality, etc.), which prevents them from engaging in adequate 
preventive health care or self-care and makes them more vulnerable to health 
risks – this is particularly evident during major disease outbreaks such as 
Ebola and COVID-19 (Frimpong and Paintsil 2020). Women and girls are 
therefore also a vulnerable group during disease outbreaks (Saalim et al. 
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2021). At the same time, the number of cases of gender-based violence (GBV) 
or violence against women and girls (VAWG), i.e., violence or abuse specifi-
cally targeting women or girls, also increases during outbreaks: “a pandemic, 
conflict or a disaster will exacerbate pre-existing gendered structural inequal-
ities and [...] leaves women and girls more vulnerable, fueling impunity for 
the perpetrators” (Javed and Chattu 2021, 33). Patriarchy is at the forefront of 
the causes of gender-based violence. Increased domestic violence due to 
mass quarantine measures or violence triggered by psychological stress dur-
ing disease outbreaks exacerbate the situation of women and girls. Experi-
ence with Ebola outbreaks suggests that the protection of girls and women or 
vulnerable groups should be included in crisis management strategies (ibid.). 
The literature we reviewed also mentions people who have developed mental 
disorders triggered by health crisis situations; it should be noted that scien-
tific research on mental illness has already increased in relation to outbreaks 
of Ebola and this has increased again, especially due to the global spread, with 
COVID-19 (Maalouf et al. 2021). Accordingly, not only are vulnerable groups 
particularly affected in acute public health crises, but the crisis situation can 
also give rise to (future) vulnerable groups that also need to be protected. The 
prioritization of health in relation to preventive measures is also criticized 
with regard to these effects, and the question of a trade-off is called for with 
demands for the consideration of vulnerable groups in crisis management. 
A final aspect that we have included under our “Prioritization of health” 
category is the impact on cultural practices. The consideration of cultural 
practices in public health measures for infection control is a key lesson 
learned from the Ebola epidemic in West Africa. Already with Ebola, specifi-
cally in Sierra Leone, it was noted that international aid workers who were 
relied upon for control placed their containment and control measures (e.g., 
no home care, no local burial practices) above local and traditional practices 
without realizing the community importance of the practices or what nega-
tive consequences for communities resulted. For example, caregivers’ lack of 
knowledge that family involvement in care and burials are important social 
and cultural values and cannot simply be abandoned - which subsequently 
led to conflict (Richards 2020). In this context, knowledge of local or cultural 
needs can provide important information for disease control, e.g.,  
The information was of epidemiological significance, since at death a 
woman’s body belongs to her patrilineage and will be buried in her own vil-
lage by her brothers and sisters and not in the village of her husband, unless 
a lifelong series of obligations by the husband’s family has been completed. 
(ibid., 499) 
Aid workers then appropriated this social and cultural knowledge and 
adapted relief efforts accordingly by supporting local and community aid 
workers – allowing for more precise and rapid containment of Ebola without 
directly influencing cultural practices (ibid.). 
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But despite culturally sensitive adaptation strategies to contain outbreaks 
such as Ebola, it is apparent that these strategies have not always been used 
and often prevention and protection measures have directly influenced cul-
tural practices. One example is the challenge of mass quarantine measures – 
especially when regular physical contact is part of social culture – which were 
used more restrictively during COVID-19 than during Ebola (Afolabi et al. 
2021). Examples of the increased influence on cultural practices by COVID-19 
have been seen, for example, in funerals in South Africa. Because bodies had 
to be buried expeditiously and in more distant or safer locations outside com-
munities due to infection control, bereaved families could not mourn the de-
ceased because travel between provinces was not permitted for mourning 
events (Canham 2021). Complaints were made about the prioritization of 
health, which was given a higher priority than cultural practices: “In its place, 
is an incredible loneliness where custom is replaced by regulation” (ibid., 
302). Nevertheless, solutions to the burial problem were offered, such as 
“live-stream burials” in South Africa via the Internet (e.g., YouTube) to allow 
relatives to mourn their deceased at a distance; however, this solution was 
met with criticism in some areas because this practice was at odds with the 
culture of respect and seriousness that death requires (ibid.).  
Finally, looking at all four forms of health prioritization impacts related to 
Ebola and COVID-19 outbreaks, we see that this is primarily a problem for 
LICs and MICs; in these countries, the population is most directly affected by 
the impacts because they do not have sufficient resources to mitigate them:  
The positive effects of these measures, however, are not necessarily trans-
ferable to low income countries that do not have the financial capacity to 
counterbalance the negative consequences of long lockdown periods, nor 
the capacity to enforce strict containment measures country wide. (Co-
lombo et al. 2020, 418) 
It turns out that the initial assumption, often cited publicly, that the pandemic 
would affect all people worldwide equally was a fallacy – the pandemic does 
affect everyone, but not equally: countries where (opportunity) inequalities 
already existed before the pandemic were further burdened by the pandemic 
(Bundervoet and Davalos 2021).  
It is particularly problematic that the intended claim of the protective 
measures, namely, to protect health as a conditional good under all circum-
stances, in many cases ultimately and in the future led to the opposite, 
namely to the restriction of people’s health. It should be noted that for both 
Ebola and COVID-19, measures to protect health were treated conditionally – 
but this ultimately led to increased amounts of protests and negative conse-
quences. One solution to this ethical dilemma would be to weigh the right 
balance of restrictions to maintain health and quality of life in equal measure. 
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4.4 Is there Fair Access? 
In 2017, the World Health Organization (WHO) and The World Bank pub-
lished a Global Monitoring Report on “Tracking Universal Health Coverage” 
(WHO and The World Bank 2017). It states that “at least half the world’s pop-
ulation still lacks access to essential health services” (ibid., v). Closely related 
to this finding are the so-called Social Determinants of Health (SDH),3 which 
can have a major impact on the health outcome of individuals worldwide in 
both LIC and HIC – ultimately, wherever “social determinants have a direct 
link to the economic and social opportunities afforded to one population over 
another.”4 Thus, these determinants include non-medical aspects, such as 
economic stability, education, food security, or access to health services, 
which can play a crucial role in keeping people healthy. 
In the context of major disease outbreaks such as Ebola and COVID-19, the 
aspect of “Equal access to resources” plays a significant ethical role when it 
comes to the preservation of public health because access determines the 
health of people in a direct or indirect way. In the literature we examined, we 
were able to distinguish three different types of resources for which equitable 
access was not ensured in the context of disease outbreaks and which were 
criticized: access to protective materials, to technology, and to research. 
Again, it is striking that these inequities are predominantly found in relation 
to countries from sub-Saharan Africa. Many of these countries have no or 
limited access to protective materials – both at the individual and public lev-
els. At the public level, insufficient testing capacity or appropriately available 
laboratories were cited to test people for COVID-19, which worked against in-
fection prophylaxis (Colombo et al. 2020; Juma et al. 2020; Nachega et al. 2020; 
Afolabi et al. 2021). For example, one national laboratory in the capital, Kin-
shasa, was responsible for all COVID-19 RT-PCR testing in DRC, which also 
resulted in severely delayed test results (Nachega et al. 2020); the same prob-
lem of inadequate testing conditions was identified for Ebola. But it was also 
reflected that while Ebola in Sierra Leone has developed a solid concept of 
contract-tracing, quarantine, and testing, COVID-19 ultimately brought other 
challenges, e.g., diagnostics based on symptomatology, delivery of equip-
ment when the world is in lockdown, or the government’s lack of payment 
for technology and training of personnel (“post-Ebola bankruptcy”; Richards 
2020, 497). In contrast, at the individual level, inadequate access to personal 
protective equipment (such as face masks, gloves) or measures (such as hand 
hygiene, use of disinfectants) is evident for the general population as well as 
for health care workers (Juma et al. 2020; Nachega et al. 2020; Afolabi et al. 
 
3  World Health Organization. Social determinants of health (SDH). https://www.who.int/health-
topics/social-determinants-of-health#tab=tab_1 (Accessed August 10, 2021). 
4  Van Houten, Frans. 2020. Here’s how to improve access to healthcare around the world. World 
economic forum. https://www.weforum.org/agenda/2020/01/tackling-healthcare-access-con-
straints/ (Accessed August 10, 2021). 
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2021; Erlach et al. 2021). Thus, not every household has the means to “afford” 
infection prevention even when sufficient education on prevention measures 
exists – these health prevention requirements are particularly tragic or diffi-
cult to implement in regions where a large proportion of the population lives 
in precarious conditions where access to running water is scarce and no san-
itation or hygiene infrastructure is available (Afolabi et al. 2021). 
Another aspect concerns the use of technology or technical devices for out-
break control in African countries where digital and other structural inequal-
ities prevail. On the one hand, criticism was levelled at the lack of access to 
technology, and on the other hand, the use of available but not context-spe-
cific technology from outside. To enable bereaved families to attend the fu-
neral ceremony of deceased relatives, digital solutions were used in South Af-
rica during COVID-19, for example, to comply with distance measures in 
terms of infection control. However, the problem was that not all people had 
equal access to this technical option due to their financial situation – accord-
ingly, they were excluded from funeral ceremonies of their relatives (Can-
ham 2021). 
The criticism regarding context-specific technology refers to the primarily 
adopted “technic-centric” perspective versus a “socio-technical” perspective, 
i.e., “neglect of the interplay between technology and its societal context of 
deployment by focusing on the techno-economic benefits of a given technol-
ogy” (Arakpogun et al. 2020). The technology often developed in HIC is ini-
tially context-specific for these countries; it relates to the environment and 
needs experienced there. If technology is intended for other cultural spaces 
or countries, developers are faced with the challenge of developing the tech-
nology specifically for the targeted local context – if this is not successful, this 
is referred to as the “design-reality gap” (ibid.). A general overlay of technol-
ogy – based on the mistaken idea that the same conditions prevail everywhere 
– on countries that have different basic conditions and different local needs 
may not lead to the desired goals or may even have negative consequences 
(ibid.). For example, it was noted that during the 2013 Ebola outbreak in Si-
erra Leone, contact tracing of infected people was done by local health teams 
who had the local knowledge to locate people and provide them with quaran-
tine information; during COVID-19, a smartphone application was then de-
ployed to do just the same, but ultimately proved ineffective, was abandoned, 
and reverted (with great success) to local health teams. Realizing the ineffec-
tiveness of this technique in the specific setting took time and risked infec-
tion: 
The larger lesson, then, is that the functionality of a contact tracing system 
depends not on whether it deploys “world-beating” technology but on how 
capable it is at recognizing and responding to the realities of the complex 
social webs within which infected persons live. (Richards 2020, 498)  
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Finally, equitable access to research is an issue that was relevant to affected 
countries in the context of the Ebola and COVID-19 outbreaks. In this regard, 
our database, with reference to countries in sub-Saharan Africa and COVID-
19, cites the issue that there was insufficient access to epidemiological re-
search data of their own countries to determine safer forecasts or public 
health interventions: “epidemiological studies are needed to better under-
stand the transmission patterns, assess the health and overall impacts of the 
epidemic, and evaluate the effects of containment measures” (Colombo et al. 
2020, 415). In a similar way, it was already criticized in the case of Ebola that 
there was a failure in the (especially rapid) dissemination of research data, 
which ultimately led to delayed assessments and actions in infection control 
(Afolabi et al. 2021). Accordingly, it could already be learned from Ebola that 
a fast and transparent handling of research data is also desirable in the fight 
against COVID-19 – at the same time, however, it was also stated that such 
open science concepts should always be used in an ethically reflected manner 
(e.g., with regard to due diligence, data protection, spillover effects of prem-
ature results, etc.; Khanali, Malekpour, and Kolahi 2021). 
It was also critically reflected that research and production mostly took 
place outside, mainly in HIC, without the involvement of the affected coun-
tries – which ultimately led to a lack of acceptance of the research results and 
products, such as vaccines, by the people:  
The skepticism towards COVID-19 vaccines appears to be associated with 
the fact that vaccine manufacturers and scientists have been predominately 
from Europe and North America, raising suspicions of neocolonialism 
through medical research. (Kasozi et al. 2021, 253) 
Another aspect in this context is the handling of intellectual properties. It is 
argued that access to research results and products is ultimately made even 
more difficult by patenting (intellectual property rights vs. public health in-
terests), i.e., even if countries have access to research results in the first in-
stance, access to products such as drugs or vaccine doses can be made more 
difficult by patenting in the second instance (Motari et al. 2021).  
Interestingly, access equity related to vaccines was not an issue in the arti-
cles in our database. This could possibly be related to the fact that at the time 
the articles were published in our database (2020-2021), the topic of vaccines 
was relatively new (first COVID-19 vaccine issued in December 2020 by the 
US Food and Drug Administration) and issues of access or even distribution 
equity did not yet arise or would not arise with further vaccine approvals and 
production.  
In conclusion, a direct comparison between Ebola and COVID-19 also 
shows in the category “Equal access to resources” that these disease out-
breaks present a problem in terms of equitable access to resources – but often 
in a more pronounced way for COVID-19. It turns out that the disparities we 
see in the COVID-19 response can be attributed to the fact that Ebola 
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outbreaks predominantly affect LICs and LMCs, so they are all similarly dis-
advantaged, whereas with COVID-19, people are affected on a global scale. 
Inequity in access shows up in our database in an amplified way in countries 
where inequities already exist and disease outbreaks or crises contribute to 
exacerbating these inequities, and this unequal access has consequences for 
people’s health. 
4.5 Communication: A Matter of Caring and Empowerment? 
Communication in crisis situations is a crucial tool when it comes to protect-
ing people. Particularly during major disease outbreaks where there is a 
threat to life or health due to the specific event, adequate information or com-
munication with the public contributes to public health, e.g., to warn, edu-
cate, and empower people. Accordingly, unethical (communication) behav-
ior can undermine the imperative of care that government and public 
officials have toward fellow human beings, e.g., when proper information 
about the current state of knowledge of the situation is not conveyed or even 
when false news is used for one’s own staging or sensationalism. Professions, 
such as the medical profession, politicians, or media representatives, have 
certain codes of ethics, which also, or especially in crisis situations, allow eth-
ical and professional action to be expected: “Such codes aim to ensure that 
individuals belonging to certain professionals act in a way that is ethically and 
professionally consistent with that which might reasonably be expected” 
(Quinn 2019, 19). Nonetheless, the Ebola and COVID-19 disease outbreaks 
demonstrate that the imperative to care for the public has not been met in 
various ways. The category “Adequate Information” subsumed content from 
articles in our database that criticized unclear, premature, or inaccurate in-
formation during these disease outbreaks (Brown and Mari Sáez 2020; Hauer 
and Sood 2020; Afolabi et al. 2021; Erlach et al. 2021; Kasozi et al. 2021). Among 
these, it was argued that the hasty promotion of herbal agents in Uganda as a 
cure for COVID-19 has led to uncertainty and a loss of public acceptance to-
ward the use of vaccines; similar experiences, which subsequently led to vac-
cine skepticism, have already been noted with Ebola (Kasozi et al. 2021). Al-
ready with Ebola, there have been various myths, misconceptions, and 
misunderstandings that have arisen around the virus and the disease, limit-
ing an effective public health response and hindering research; COVID-19 
also presented such public communication challenges (Afolabi et al. 2021); 
for example, rumors arose “that COVID-19 does not pose risks to those who 
are not white or rich” (Erlach et al. 2021, 17), so that everyone else would be 
protected from it, or rumors that “people with dark complexion do not get 
infected with SARS-CoV-2; hot tea, lime drinks and pepper soup can cure 
COVID-19; and medical face masks imported from China were infected with 
SARS-CoV-2” (Afolabi et al. 2021, 27). In addition, the articles state that it is 
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the task of government representatives or even organizations such as the 
WHO to protect public health and that they therefore have a decisive role in 
communication. For example, in sub-Saharan Africa, there is criticism that 
public crisis communication there makes COVID-19 less of a threat and more 
of a political purpose for the disease, i.e., there is a distrust of the government 
with regard to its communicated contents, especially because the required 
measures (wearing masks, keeping distance) are not observed by public rep-
resentatives, such as politicians, police, or military (Erlach et al. 2021). It is 
expressed that public persons and also institutions do not only have the task 
to give clear information, but also to deal adequately with uncertainties, es-
pecially with outbreaks of so far unknown diseases, e.g., in case of missing 
scientific evidence or still outstanding information: “Their challenge is to ad-
dress uncertainty in a context where scientific evidence is absent and the au-
thority of scientists, in general, is questioned” (Jong 2020, 966).  
The WHO has also been criticized in this regard – it was noted that the or-
ganization used negative rhetoric in communicating the Ebola outbreak in 
West Africa compared to the COVID-19 outbreak in China; the criticism here 
is that this created a global influence on the perception of the two outbreaks 
and the resulting consequences or support for the affected countries (Ho, Li, 
and Whitworth 2021). Such unbalanced communication can lead to different 
results, e.g., fears can be stirred up, negative behavior in the public can be 
provoked, or stigma can be caused (Brown and Mari Sáez 2020; Shrum et al. 
2020). Even the declaration of a disease outbreak as an epidemic or pandemic 
can cause certain fears. Accordingly, reflected crisis communication is al-
ready necessary at this meta-level (Shrum et al. 2020). It can be seen that, in 
particular, culturally sensitive crisis communication often already eliminates 
many threats – for example, it was already found in the case of Ebola that a 
“bottom-up” strategy in controlling the outbreaks was more promising – as 
people resisted or subverted ordered protective measures in “top-down” 
strategies, such as mass quarantine, in order to survive; similar experiences 
can be noted with regard to strategies against COVID-19 (Johnson and 
Goronga 2020; Nachega et al. 2020).  
So-called fake news is of particular importance in crisis communication, 
especially in the case of outbreaks of disease. Although fake news has been 
around since journalism began, the term has increasingly become the focus 
of public debate in recent years and has grown in scope and significance, es-
pecially due to the internet:  
Manipulation, disinformation, falseness, rumors, conspiracy theories – ac-
tions and behaviors which are frequently associated with the term – have 
existed as long as humans have communicated. The novelty of the term in 
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this context relates to how false or misleading information is produced, dis-
tributed and consumed through digital communication technology.5  
For example, the Cambridge Dictionary defines the term fake news as “false 
stories that appear to be news, spread on the internet or using other media, 
usually created to influence political views or as a joke.”6 Fake news poses a 
particular challenge in public crisis communication. Due to the high reach of 
modern communication technologies such as social media, information 
reaches the public unfiltered and thus also influences the management of a 
crisis (Quinn 2019; Hauer and Sood 2020). Especially in crisis situations, fake 
news poses a high-risk potential since it is not (always) clear to the public or 
media consumers whether the information is harmful or useful. The dissem-
ination of such misinformation is particularly problematic when it is carried 
out by public figures who represent authorities in society or are highly 
trusted. Particularly during the COVID-19 pandemic, there was increased 
criticism of fake news in crisis communication that contradicted the require-
ment of truthfulness (Druml 2020; Jong 2020; Smyth 2020). In the category 
“Adequate information,” the focus is on countries worldwide, i.e., LICs/LMCs 
and HICs/UMCs are addressed or included in almost equal proportions; the 
topic of fake news was specifically addressed only with reference to HICs 
(specifically the USA). 
4.6 Do Health Care Workers Have a Choice? 
“Healthcare industry is one of the most hazardous environments to work in. 
Employees in this industry are constantly exposed to a complex variety of 
health and safety hazards in the course of their work” (Joseph and Joseph 
2016, 71). Health care workers in frontline settings, such as large disease out-
breaks, are at even greater risk of harm, both physically and psychologically 
– this has already been seen in the Ebola outbreaks (Doshi et al. 2020) as well 
as in the COVID-19 pandemic (Nguyen et al. 2020). In our articles, we were 
able to identify contents that address the very risks that healthcare workers 
face in disease outbreaks, not of their own accord, but for reasons of solidar-
ity or professional ethics. In addition to the increased risk of infection, 
healthcare workers are also exposed to psychological and emotional stress 
(Mohindra et al. 2021; Myles et al. 2021; Sasidharan and Dhillon 2021). These 
include, for example, fears of infecting family members or close relatives 
(Myles et al. 2021), security risks during armed conflicts (e.g., during COVID-
19 in DRC; Sasidharan and Dhillon 2021), or stigmatization experiences by so-
ciety (shunning, abuse, violence; Mohindra et al. 2021) – these aspects are 
 
5  Kalsnes, Bente. 2018. Fake News. Oxford Research Encyclopedia of Communication. 
https://doi.org/10.1093/acrefore/9780190228613.013.809. 
6  Cambridge Dictionary. Fake news. https://dictionary.cambridge.org/de/worterbuch/englisch/ 
fake-news (Accessed August 10, 2021). 
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empirical values that were already identified during Ebola and are now again 
an issue during COVID-19. Such reactions towards healthcare workers may 
be explainable (not excusable) from a counter perspective: (potential) pa-
tients avoid using healthcare services for fear of being infected by healthcare 
workers (Colombo et al. 2020). Based on the experience with Ebola, support 
measures could be established for the increased stress of healthcare workers 
to support them before, during, and after a mission (Myles et al. 2021), also, 
e.g., by establishing anti-stigma measures (Mohindra et al. 2021). 
There is a question that arises when considering these increased burdens 
that health care workers expose themselves to on behalf of others: is it a duty 
to expose oneself to increased risks as a health care worker in order to help 
or protect others? A “Guidance in a pandemic” published specifically for the 
COVID-19 outbreak based on the AMA Code of Medical Ethics under Opinion 
8.3 responds to this by stating that “physicians have an obligation to provide 
urgent medical care during disasters. This obligation holds even in the face 
of greater than usual risks to physicians’ own safety, health, or life.”7 How-
ever, this professional ethical obligation is primarily one designated within a 
code and not a law.  
This leads to another question: is a healthcare worker allowed to evade such 
(professional) duties for his own protection? One article in our database ad-
dresses this very ethical dilemma with reference to a specifically Jewish per-
spective:  
The classic Jewish sources have dealt with this question as well. There is an 
obligation “to not stand by idly when you [sic] friends life is in danger”; how-
ever, the question arises as to whether there are limits to this obligation? Is 
one required to risk one’s own life to save another person? (Solnica, Barski, 
and Jotkowitz 2020, 441) 
The authors of the article list four different responsibilities that a health care 
worker, specifically a physician, has towards patients: ethical responsibility 
(it is Jewish tradition to visit and treat the sick, this ultimately applies to pa-
tients with an infectious disease), professional responsibility (it is a profes-
sional duty to care for the sick; modern notion of ethical responsibility shared 
by all physicians as members of the profession), societal obligation (society’s 
expectation that health care workers care for the sick), and permission to care 
for the sick (health care workers not only have an obligation to care for the 
sick in the practice of their profession, but they also have permission to do 
so). Finally, the authors conclude that healthcare workers have different ob-
ligations to their patients and should take risks to do so, but at the same time 
there should be an obligation (e.g., on the part of hospitals) to provide the 
best possible protection to health care workers (Solnica, Barski, and Jotkowitz 
 
7  American Medical Association. 2020. AMA code of Medical Ethics: Guidance in a pandemic. 
https://www.ama-assn.org/delivering-care/ethics/ama-code-medical-ethics-guidance-pan-
demic (Accessed August 10, 2021). 
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2020). Thus, in another article in the database, it was found that this granted 
protection for health care workers is ultimately an important indicator of 
willingness to cooperate in crisis situations; here, it is shown that lack of trust, 
lack of guarantee of safety, and the type of crisis situation at hand (e.g., lower 
willingness to help in Ebola than in COVID-19 outbreaks and highest willing-
ness to help in natural disasters) can all negatively impact health care work-
ers’ willingness  to assist (Sultan et al. 2020). 
It turns out that health care workers are not only exposed to a high health 
burden but additionally to a duty of solidarity, which maneuvers them into an 
ethical conflict situation, should they decide in favor of their own health. One 
possible way out is the increased protection and support of health care work-
ers – so that the “way forward is no longer ‘Physician heal thyself’ but ‘Physi-
cian protect thyself’” (Joseph and Joseph 2016, 72) to perform their duties. 
4.7 Do Disease Outbreaks Trigger Stigma and Discrimination? 
Based on Erving Goffman’s account of “stigma” ([1963] 1990), Link and Phelan 
(2006) describe a five-stage process (consisting of labeling, stereotyping, sep-
arating, loss of status, and discrimination) leading to stigma and negative 
health implications (Link and Phelan 2006). These health implications refer 
primarily to the affected or stigmatized person, since a “second illness” is ex-
perienced as a result of the stigma (Finzen 2000) – for example, through dis-
criminatory, negative behavior towards the person, such as violence or shun-
ning, which can also extend to surrounding groups of people in the social 
environment of the person affected (so-called courtesy or associative stigma; 
Goffman [1963] 1990; Mehta and Farina 1988). 
Specifically, for disease-related stigma and discrimination during disease 
outbreaks against humans, the health consequences for affected individuals 
can also become a public health risk because disease containment is compro-
mised, or the risk of infection is not mitigated (Fischer et al. 2019). Stigma 
experience and discrimination could be identified in the articles in our data-
base for both Ebola and COVID-19. Similarities can be observed with regard 
to the forms of stigma and discrimination: The focus is particularly on mar-
ginalized groups, i.e., “those who, to varying degrees, exist politically, so-
cially, or economically ‘outside’ of dominant norms and institutions” (Cohen 
1999, 37). Thus, marginalized groups have been stigmatized and discrimi-
nated against because of their appearance, language, origin, or religion in re-
lation to the virus or disease (equally so for Ebola and COVID-19) in various 
countries worldwide (Dionne and Turkmen 2020; Lee, Huang, and Schwarz 
2020; Afolabi et al. 2021; Canham 2021). The consequences are lower utiliza-
tion of health services by those affected, even in the presence of certain 
symptoms, or denial of symptoms for fear of stigma (Dionne and Turkmen 
2020; Afolabi et al. 2021). In general, the impact of disease outbreaks is found 
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to disproportionately affect marginalized groups more than the rest of society 
(Dionne and Turkmen 2020; Smyth 2020; Richards 2020; Canham 2021) – an 
explanation of why this focus exists is also addressed in the articles: it has 
been argued that marginalized groups also experience forms of hostility in 
society outside of disease outbreaks, and that they are used as “scapegoats” in 
crisis situations (Canham 2021). Another explanatory approach to stigma and 
discrimination with specific reference to xenophobia in disease outbreaks 
traces this back to fears of the (individual’s) disease: people’s tendency to 
avoid disease risks can lead to an overgeneralized avoidance of foreign, unfa-
miliar entities, even if they do not represent actual disease vectors – creating 
xenophobia (Lee, Huang, and Schwarz 2020). Ultimately, the assumption that 
“infectious disease triggers stigma, and stigma worsens disease” (Brewis, 
Wutich, and Mahdavi 2020) can be supported with regard to the contents of 
our literature. 
4.8 A Dilemma of Human Research?  
The basic dilemma of medical research involving human subjects is reflected 
in the interest of knowledge (general benefit) on the one hand and the interest 
of subjects (individual protection) on the other. Accordingly, bodies (e.g., eth-
ics committees) and ethical principles (e.g., Declaration of Helsinki; WMA 
2013) have been established in clinical research, which represent shared 
norms and values of the scientific community and society; here, the ethical 
evaluation of study designs or the treatment of subjects plays a role. Under 
this premise, the category “Research ethics” includes content from articles 
that ethically reflect on the development of vaccines in the context of disease 
outbreaks. One aspect that was relevant during both the Ebola outbreak in 
West Africa and the COVID-19 outbreak was that at the time of the outbreaks, 
there were no researched drugs or vaccines available to combat the virus or 
to treat people. In both virus scenarios, pressure to act arose, on the one 
hand, to develop and produce appropriate agents as quickly as possible to 
protect human lives and, on the other hand, to establish research processes 
involving care and time to also protect people – both aspects collided during 
the outbreaks.  
For COVID-19, this situation was countered with an accelerated vaccine de-
velopment strategy (Uttarilli et al. 2021); this was also made possible in par-
ticular by the global spread of the virus and thus the participation of many 
countries. A similar approach was taken to the Ebola outbreak in West Africa, 
but, in addition, the use of experimental agents was permitted under defined 
ethical conditions (WHO 2014). The articles in our database address both ab-
breviated vaccine and drug research and the use of unapproved agents, e.g., 
in compassionate use concepts (Druml 2020; Afolabi et al. 2021). The main 
criticism here is the potential harm that can occur for humans if active 
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substances are not adequately studied in abbreviated clinical trials (Afolabi et 
al. 2021), but also the resulting possible breach of trust in science and re-
search, which can result in “vaccine hesitancy” (Smyth 2020). The acute re-
search pressure during the Ebola outbreak in West Africa provided lessons 
regarding ethical aspects of study design, including transparency for all par-
ticipants in the study process and adherence to local ethical standards (Wolf 
et al. 2020). The question of the use of placebos also arose anew in light of the 
Ebola and also COVID-19 outbreaks: unlike COVID-19, during the Ebola out-
break in West Africa, the use of placebos in clinical trials was deemed uneth-
ical by several countries due to the high mortality rate and difficulty in provid-
ing adequate care to ill patients (Wolf et al. 2020).  
An article in our database addresses another aspect relevant to research 
ethics, which also concerns the protection of humans involved in clinical tri-
als and explores the question of whether it is ethically justifiable to test an-
other vaccine in a clinical trial in humans when an effective vaccine is already 
available (Monrad 2020). In this regard, the authors in this article present var-
ious arguments that contradict such an additional burden on humans: if an 
effective agent is available, it should not be withheld from individuals if their 
lives may depend on it. To a particular extent, this applies to individuals who 
have been involved in research in resource-poor settings, where outbreaks 
are most common – they are hardest hit by withholding effective agents. Fur-
thermore, it is argued that the hope for vaccines neglects other prevention 
and protection measures to counter an outbreak. However, it is countered 
that it may be ethically justified to research additional vaccines alongside an 
existing one if that candidate vaccine is expected to have advantages over the 
existing one (ibid.). 
4.9 Appropriate Balance of Freedom and Protection? 
Particularly during the COVID-19 pandemic, the term “social distancing” has 
become widely used to imply a protective or preventive measure, namely 
keeping people apart to stop the spread of the virus – yet the term is com-
pletely misleading, as it is less about social distance and more about physical 
distance to prevent infection; accordingly, a change of term to “physical dis-
tancing” is now being solicited in order to communicate adequately in future 
disease outbreaks (Sørensen et al. 2021). In the case of both Ebola and COVID-
19, physical distancing measures or, in other words, liberty-restricting 
measures play a role in the protection against infection. The ethical implica-
tions here concern the just balancing of solidarity-based protection vis-à-vis 
society and the freedom of the individual.  
The articles that we have subsumed under the category “measures restrict-
ing freedom” contain various criticisms of measures that are not operated in 
a balanced manner. For example, it is stated that people are burdened to 
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different extents and thus unfairly by liberty-restricting measures as infec-
tion control; in this context, reference is made, on the one hand, to unequal 
effects of such measures in countries with fewer resources when compared 
with countries with a better infrastructure (Leach et al. 2021) and, on the 
other hand, to particularly vulnerable persons in a society, such as dying pa-
tients (Voo, Senguttuvan, and Tam 2020).  
To enable patient and family contact during isolation measures, different 
“presence options” (physical, virtual, vicarious) were ethically reflected –
with the result that the options have to be weighed individually (also with re-
gard to varying guidelines). In the case of physical presence, for example, it 
is apparent that there are inequities in the way it is handled; in some coun-
tries there are absolute bans on visiting patients, while in others exceptional 
cases are permitted. Visiting bans, especially with regard to family members, 
can also have negative spillover effects, so that potentially infected persons 
do not take advantage of health measures because they expect to be isolated 
from their family (Voo, Senguttuvan, and Tam 2020). But virtual presence via 
electronic communication tools also reveals ethical challenges, such as re-
source or connection limitations or protecting the privacy of other isolated 
patients. The deputy presence, in which health care workers take on the role 
of relatives to a certain extent, represents an additional emotional burden for 
them in addition to the general one caused by their work. The trade-offs re-
garding access to patients in isolation measures are particularly serious when 
the patients are children or dying (Voo, Senguttuvan, and Tam 2020). It be-
comes apparent that new forms of closeness and distance have to be negoti-
ated through isolation measures, especially towards persons (groups) with 
whom there was normally unrestricted close social and physical contact – “to 
maintain the oxymoronic intimacy implied in the term ‘social distance’” 
(Brown and Mari Sáez 2020, 24). 
A central point of criticism in the articles in our database is the restriction 
of fundamental rights concerning freedom. For example, the position is 
clearly stated that any restriction of individual liberties in favor of social se-
curity is a restriction of human rights. Such an encroachment can only be 
justified “if it is based on the rule of law and observes the principle of propor-
tionality, if only the less severe means are to be used” (Druml 2020, 401). A 
further ethical dimension is cited when considering the aspect of surveillance 
in isolation measures, e.g., ensuring that infected persons also isolate them-
selves. Among other things, smartphone apps have been used to monitor 
COVID-19-infected persons in quarantine at home – this surveillance repre-
sents an encroachment on the fundamental right to privacy (Druml 2020). 
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4.10 Where is Health Equity Lacking? 
“Life expectancy and healthy life expectancy have increased, but unequally. 
There remain persistent and widening gaps between those with the best and 
worst health and well-being.”8 This WHO statement on health inequity refers 
to inequalities that can be identified at the global level both within and be-
tween countries and are closely related to the SDHs already mentioned. The 
health inequalities are particularly evident in the comparison between 
poorer and richer populations, e.g., life expectancy for people in LIC is 18 
years lower than that in HIC.9 Disease outbreaks exacerbate such injustices, 
prompting calls for global justice not only in the current COVID-19 pandemic 
but also already in past Ebola outbreaks. In the articles in our database, con-
tent on the topic of global health justice has been inductively extracted. The 
criticism is that COVID-19 in particular is showing a trend toward national-
istic attitudes and a retreat from international solidarity, for example with re-
gard to the availability of medical products: “they act according to the motto 
‘everybody for himself’” (Druml 2020, 401). Injustices are made more appar-
ent by the global impact of COVID-19. For example, while Sierra Leone was 
still receiving humanitarian support from the United Kingdom during the 
Ebola outbreak (particularly due to historical dependencies), this support 
ceased during COVID-19, and this shows: “In a pandemic, every country has 
the disease, and international help and mutuality are at a premium” (Rich-
ards 2020, 497). With regard to the Ebola outbreaks, experience has already 
been gained on how to address disease outbreaks in solidarity in a “whole-of-
world” approach through cross-border resource sharing, cooperation, and 
synchronized pan-global containment efforts (Ebrahim et al. 2020). And yet, 
while lessons are being learned from past outbreaks and taken into account 
for future crisis management, no specific moral lessons are being learned – 
especially with regard to solidarity and justice: “unless we appreciate that we 
have a defect in our collective moral attitude toward remediating the condi-
tions that precipitate the emergence of outbreaks, we will never truly learn” 
(Smith and Upshur 2020, 564). The problem of global health equity can there-
fore be described as a lack of motivation to address inequities rather than a 
lack of existing opportunities to address them. 
4.11 Do Disease Outbreaks Burden the Environment? 
As mentioned above, outbreaks not only affect the health of the population 
but also have an impact on social processes and structures. An ethical level 
of consideration that has been missing so far and could be obtained 
 
8  World Health Organization. Social determinants of health (SDH). https://www.who.int/health-
topics/social-determinants-of-health#tab=tab_1 (Accessed August 10, 2021). 
9  World Health Organization. Social determinants of health (SDH). https://www.who.int/health-
topics/social-determinants-of-health#tab=tab_1 (Accessed August 10, 2021). 
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inductively as a category in our dataset is an environmental one – specifically, 
the interaction between humanity and nature that influences our health. For 
example, one article addressed the fact that an ecological perspective on our 
(surrounding) world has been missing until now, which is why there is an 
increase in health-threatening disease outbreaks (ten Have 2020). Man-made 
outbreaks, such as Ebola and COVID-19, are not spontaneous natural events; 
they represent the result of a disconnect between humans and nature in 
which nature is viewed as a resource and serves as such. Accordingly, only a 
changed view of the human being, embedded in the (surrounding) world, of-
fers the prerequisite for protecting health in the long term: “The ecological 
perspective therefore stresses the need for solidarity. This is not just an ethi-
cal requirement, but a medical necessity” (ibid., 528). 
In addition to this meta-level consideration, an additional criticism is made 
in an article addressing the amplification of climate change by disease out-
breaks. Compared to the Ebola outbreaks, COVID-19, due to its global spread, 
has seen an increased global response to the virus and disease with resources 
(albeit to varying degrees due to availability). Thus, there is an environmental 
burden from increased use of disposable (plastic) materials (e.g., gloves, 
gowns, face protection) and chemical (antimicrobial) agents (e.g., infectious 
agents) in clinical, research, and private settings – further compounding the 
existing environmental burden (Smyth 2020). As was also noted previously, it 
appears that the fight against climate change is also stalled during disease 
outbreaks rather than being the first priority. Even though initially mass 
quarantine measures made a positive impact on carbon dioxide pollution due 
to dramatically reduced mobility, it is apparent that prioritizing pandemic re-
sponse ultimately created losses in environmental and climate protection 
(Smyth 2020), ultimately affecting global health and the health of the world. 
5. Conclusion 
Referring to the “Principles of Biomedical Ethics” (Beauchamp and Childress 
2009), Druml (2020, 402) concludes on disease outbreaks that “the general eth-
ical principles are always the same, namely justice and solidarity, benefi-
cence, non-maleficence and autonomy.” This conclusion can be drawn fun-
damentally as well for our examination of ethical challenges in Ebola and 
COVID-19 (see table 2), but our study also shows that these challenges need 
to be considered in a differentiated way.  
Thus, the nine different ethical categories identified in our study apply 
equally to the Ebola outbreaks and the COVID-19 pandemic, even though they 
are fundamentally different diseases. At the same time, the analysis shows 
that ethical challenges differ with respect to the degree or type of affected-
ness; these differences are particularly evident with respect to the countries 
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in which the outbreaks occurred, e.g., Ebola outbreaks were exclusively rec-
orded in LICs that had fragile health systems. The outbreaks had a far-reach-
ing impact on people’s health and livelihoods there. Ebola areas that were 
then additionally affected by the COVID-19 pandemic were particularly hard 
hit in this regard. In contrast, people around the world were affected by the 
COVID-19 pandemic, but not to the same extent – here, people in LICs suf-
fered greater health and livelihood impacts than those in HICs. 
The different ways of dealing with the Ebola outbreaks (especially protec-
tive measures) and the COVID-19 pandemic, which led to far-reaching, ethi-
cally charged economic, cultural, and social consequences, are particularly 
striking – here, it became clear that universal measures in outbreak regula-
tion create ethical problems and that a locally adapted strategy is more prom-
ising. 
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